Mark G. Edwards is Director at ACELRX PHARMACEUTICALS INC (ACRX). They have made 13 open-market trades across 1 company since 2011, most recently 2021-06-17.
CIK 0001190429
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
13 open-market purchases totalling $751K since 2011, never a sale. Across 13 scored buys the stock is down 4.9% at ninety days, and 7.9 points behind the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ACRX | 261,250 | $225K |
Shares reported on the most recent Form 4, priced at the 2021-06-17 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 54% | 54% | 15% |
| Avg Move | -1.7% | +6.1% | -4.9% |
| Alpha | -0.5% | +5.4% | -7.9% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACRX | BUY | 2019-11-12 | 2019-11-12 | $1.78 | $45K | -5.7% | +31.3% | -4.0% |
| ACRX | BUY | 2019-08-23 | 2019-08-26 | $2.19 | $33K | +5.9% | +3.2% | -18.0% |
| ACRX | BUY | 2019-03-12 | 2019-03-12 | $2.99 | $114K | +1.9% | +9.0% | -23.5% |
| ACRX | BUY | 2018-11-15 | 2018-11-15 | $2.82 | $58K | +19.1% | -4.3% | -9.2% |
| ACRX | BUY | 2018-08-07 | 2018-08-08 | $2.84 | $15K | -4.8% | +3.2% | +23.8% |
| ACRX | BUY | 2018-06-01 | 2018-06-05 | $3.35 | $17K | +16.7% | +2.8% | -8.3% |
| ACRX | BUY | 2017-11-14 | 2017-11-15 | $1.90 | $57K | +15.8% | +7.9% | -9.2% |
| ACRX | BUY | 2017-08-22 | 2017-08-24 | $3.02 | $15K | +6.6% | +27.9% | -30.3% |
| ACRX | BUY | 2016-05-10 | 2016-05-12 | $3.15 | $47K | +10.1% | -0.3% | +16.6% |
| ACRX | BUY | 2015-05-07 | 2015-05-07 | $3.13 | $125K | -21.8% | -0.4% | -0.4% |
| ACRX | BUY | 2013-06-06 | 2013-06-10 | $8.10 | $81K | -21.8% | -0.4% | -0.4% |
| ACRX | BUY | 2011-12-01 | 2011-12-02 | $2.79 | $28K | -21.8% | -0.4% | -0.4% |
| ACRX | BUY | 2011-11-14 | 2011-11-16 | $2.90 | $116K | -21.8% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.